Genentech Presents Positive Results from Pivotal Study of Atezolizumab in Specific Type of Advanced Bladder Cancer at 2015 ECC
September 27, 2015 at 06:43 AM EDT
Genentech, a member of the Roche Group (OTC: RHHBY), today announced early results from a pivotal Phase II study, ...
